Registration - Organization

AstraZeneca Canada Inc. / Gaby Bourbara, President

Registration Information

Organization name: AstraZeneca Canada Inc.
Senior Officer Name: Gaby Bourbara, President
Senior Officer Change History
Initial registration start date: 2010-04-07
Registration status: Active
Projected end date: No date provided
Registration number: 10233-204

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 17

Lobbying Activity Reports - last 6 months: 1

Version 22 of 33 (2021-05-27 to 2021-09-01)

Registration versions:

Version 22 of 33 (2021-05-27 to 2021-09-01)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discussions with BC Government officials, organizations and elected representatives to obtain pubic funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade
Discussions with BC government officials/organizations and elected representative to obtain public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments. These discussions will take place with BC government funded programs such as the provincial Health Authorities including PHSA	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Hospitals
Discussions with BC government officials/organizations and elected representative to obtains public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments. These discussions will take place with BC government funded programs such as Pharmacare, and the BC Cancer Agency. This will include discussions on how best to conclude Product Listing Agreement discussions with each of these public entities.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's and the Biopharmaceutical investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Industry
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Science and Technology
Discussions with BC Government officials including the Ministry of Finance , organizations and elected representatives to discuss funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government and various ministries to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Finances and Budgets
Provide supply chain availability updates on AstraZeneca Canada medicines including vaccines, deemed essential for COVID-19 acute and community care.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19
Seek reimbursement for AZ's mental health and addiction pharmaceuticals through BC Pharmacare.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Mental Health and Addictions

BC Ministries/Provincial Entities

Education
Finance
Fraser Health Authority
Health
Interior Health Authority
Member(s) of the BC Legislative Assembly
Mental Health and Addictions
Nisga'a Valley Health Authority
Northern Health Authority
Office of the Premier
Parliamentary Secretary for Environment
Provincial Health Services Authority
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Jane Chung, President

Organization Contact Information

AstraZeneca Canada Inc.

Address:
1004 Middlegate Road, Ste 5000
Mississauga, ON L4Y 1M4
Canada

Telephone number: 800-565-5877 Ext. 46883

Description of Activities

Focus on Innovative Life Sciences/Economic Development Policies; Health as an Economic Generator of Wealth in British Columbia; and Health Policy/Reimbursement decisions

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Coalition Members Information

AstraZeneca Canada Inc. is not a coalition member.

Affiliates with a Direct Interest in the Outcome

AstraZeneca plc
- 2 Kingdom Street
  London W26BD,OT
  United Kingdom

Other Persons or Organizations with Direct Interests

The activities of AstraZeneca Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Mo Amin
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No